Defunct Company
Total Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
1,856
NCT01274689
External Lid Loading for the Temporary Treatment of the Paresis of the M. Orbicularis Oculi: a Clinical Note
Phase: N/A
Role: Collaborator
Start: May 31, 1997
Completion: Aug 31, 2010
NCT02395874
tDCS and Speech Therapy to Improve Aphasia
Role: Lead Sponsor
Start: May 31, 2015
Completion: Oct 31, 2018
NCT04765124
The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy
Start: Apr 29, 2021
Completion: Nov 15, 2021
NCT06605612
Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
Start: Sep 9, 2024
Completion: Jan 1, 2028